Epinephrine
Patients suffering from bronchial asthma and chronic obstructive pulmonary disease are often treated with epinephrine and theophylline (aminophylline) perioperatively. A serious problem with this potent bronchodilating combination is the potential to precipitate a fatal ventricular arrhythmia. ~'2 This is exacerbated when volatile halogenated anaesthetics and thiopentone are part of the anaesthetic regimen because of their tendency to sensitize the heart to the arrhythmogenic effect of catecholamines. 3-6 Halothane, enflurane, and isoflurane have been used successfully in the treatment of status asthma-ticus. 7.s Although halothane is more arrhythmogenic than enflurane and isoflurane, halothane may still be preferred 9 because it has some advantages over isoflurane during airway stimulation, io
In one approach to this problem, we tested the hypothesis that midazolam, compared with thiopentone for induction of anaesthesia, wouldresult in less arrhythmogenicity of the epinephrine-aminophylline-halothane combination without interfering with its bronchodilating action.
Methods

Animals
We used two groups of five mongrel dogs each of either sex with a weight range of 17.0 to 21.5 kg.
Anaesthesia and monitoring
Anaesthesia was induced with either thiopentone (Group T), 25-30 mg.kg-I iv, or midazolam (Group M), 10 mg'kg-~ iv, followed by succinylcholine, 2 mg. kg-i iv to facilitate tracheal intubation. Anaesthesia was maintained with 50% N20 in 02 plus halothane (H) at 0.9% end-tidal concentration. Pulmonary ventilation was controlled to maintain PaCO2 at 35-40 mmHg. A catheter was inserted into a saphenous vein for the administration of 5% dextrose in lactated Ringer's solution. The heart rate (HR) was recorded from lead II of the ECG using a Spacelabs monitor (Model 413A). A #8 Fr side port/haemostasis valve catheter to sheath adapter (Arrow AK-09801) was inserted percutaneously into a femoral artery for the rapid removal of blood for arterial blood gas (Radiometer Copenhagen (Model BMS MK2)) and blood chemistry analyses, and for retrograde catheterization of the femoral artery through the haemostasis valve with a #7 Fr NIH catheter to record aortic blood pressure. The arterial catheter was connected via a Bell & Howell transducer (Model 4-327-I) to a Gould amplifier module (Model 13-4218-00).
off-line by gas chromatography. Blood samples for the determination of plasma concentrations of catecholamines, theophylline and electrolytes were taken when appropriate. Plasma catecholamines were determined by HPLC with electrochemical detection II (coefficients of variation: exogenous, 5%; endogenous, 10%). Plasma theophylline was analyzed by a modification of Jatlow's HPLC method 12 (coefficient of variation 5%), and sodium and potassium were detected with an Instrumentation Laboratory Flame Photometer (Model 143, coefficient of variation 5%).
Arrhythmogenic state
This was defined by the occurrence of: (1) 
Drugs
Except for the volatile anaesthetics, drugs were given iv either by bolus injection or by infusion using a calibrated Harvard infusion pump (Model 942).
EPINEPHRINE
The minimal arrhythmogenic infusion rate (MAIRE) and minimal arrhythmogenic plasma level (MAPC) were used to determine the arrhythmogenic threshold to epinephrine. This was done by infusing epinephrine in logarithmically spaced increasing doses starting at 0.37 p.g. kg-l.min -| for five minutes each. The epinephrine infusions were stopped at the arrhythmogenic state after obtaining blood samples for physiological and biochemical analyses. The average time interval between induction of anaesthesia and the first dose of epinephrine was about two hours.
Physiological and biochemical measurements
All analogue signals were recorded on a Gould 6-channel strip recorder and on magnetic tape (Sabre tape deck, model lI). Average values for R-R interval, systolic (SBP), and diastolic (DBP) aortic pressures were obtained from the analogue tracings of three consecutive beats. Heart rate (HR) was derived from the ECG, and mean aortic pressure (MAP) from a standard formula. Endexpiratory PCO2 was measured on-line with a Capnogard infrared analyzer, and arterial blood gas (ABG) analysis was determined intermittently to confirm appropriate ventilation and acid-base status. End-tidal concentrations of halothane were measured on-line by an Emma gas analyzer (LKB Medical Inc., Model 57-70110-30) and AMINOPHYLLINE After haemodynamic variables had been stable for five minutes, aminophylline, 10 mg. kg -I, was injected over one minute. Five minutes later (Aio), haemodynamic measurements were recorded and blood samples taken. Then, the infusion schedule of epinephrine was repeated until the predetermined arrhythmic condition appeared, at which time blood samples again were taken. This aminophylline-epinephrine protocol was repeated with 20 rag" kg-i of aminophylline (A2o).
Statistics
One-(ANOVAIR) and two-way analyses of variance, Newman-Keuls tests, unpaired t tests, and paired t tests Mean values -SD of minimal arrhythmogenic infusion rate of epinephrine (MAIRE), of minimal arrhythmogenic plasma concentrations of epinephrine (MAPC), of plasma potassium (K +) and plasma aminophylline (A) concentrations and systolic blood pressure (SBP) prior to aminophylline (Ao) , and following 10 mg" k g -' (Alo) and 20 mg' kg-i (A2o) aminophylline. #Statistically significant difference from Ao at P < 0.01 by Newman-Keuls test. +, + + Statistically significant difference between A2o and A~o at P < 0.05 and P < 0.01 respectively by Newman-Keuls test and by paired t test for plasma aminophylline. *,**Statistically significant difference from T at P < 0.05, and P < 0.01 respectively by unpaired t test.
FIGURE I Mean values and SD of infusion rates of epinephrine without (Ao) and with 10 (Aio) and 20 (A2o) rag" kg -Laminophylline in midazolam and thiopentone pretreated halothane-anesthetized dogs. Statistically significant differences from baseline (#, P < 0.01), from A,o (+, P < 0.05) and from midazolam (*, P < 0.05; **, P < 0.01).
were used to establish statistically significant differences among treatments.
Results
Pertinent data are listed in Table I . At each measurement, MAIRE ( Figure 1 ) and MAPC were lower after thiopentone than after midazolam (P < 0.05 for MAIRE at Ao, P < 0.01 for MAIRE at Aio and A2o, P < 0.05 for MAPC). With aminophylline 10 mg. kg -l, MAIRE and MAPC decreased from Ao in both groups (P < 0.01). With aminophylline 20 mg-kg -t, MAIRE decreased from Aio in both groups (P < 0.05).
Linear regression between all individual MAIRE and MAPC values (Figure 2 ) yielded a correlation coefficient of 0.93 (P < 0.001).
Overall aminophylline-induced changes in SBP were statistically significant both after thiopentone and midazolam induction (P < 0.01 by ANOVAIR). After thiopentone induction, SBP at MAIRE was lower after 10 and 20 mg-kg-l aminophylline than before aminophyl- Mean values • SD of pH and PaCO2 at arrhythmogenic threshold without aminophylline (Ao) and after 10 (A,o) and 20 (A2o) mg'kg-' aminophylline after thiopentone (T, n = 5) or midazolam (M, n = 5) induction.
line (Ao). After midazolam induction, SBP was lower only after A2o when compared to Ao and Alo. At A2o, SBP was higher after midazolam than after thiopentone (163 vs 124 mmHg, P < 0.01). There were no differences in plasma aminophylline concentrations at MAIREs between the midazolam and thiopentone groups.
With thiopentone plasma potassium levels at MAIRE declined after 10 and 20 mg'kg -t aminophylline compared with Ao. Plasma potassium levels after 10 mg-kg-t aminophylline were higher with midazolam than with thiopentone (P < 0.05).
The arterial blood pH and PaCO2 values before (Ao) and after the injections of aminophylline (A~o,A20) were not different from each other within and between the two treatment groups (Table II) .
Discussion
The arrhythmogenic thresholds to epinephrine were lower with thiopentone than with midazolam at each determination, and decreased after aminophylline in a dosedependent manner ( Figure 1 and Table I) .
Compared with induction and maintenance of anaesthesia with halothane alone, thiopentone lowered the arrhythmogenic threshold to epinephrine 5 for at least four hours after injection, t4'15 The duration of midazolam's effect on arrhythmias is unknown.
Although we did not measure plasma thiopentone or midazolam concentrations, midazolam concentrations may have decreased much faster than thiopentone's throughout the study period, because midazolam has a shorter elimination half-life and faster clearance than thiopentone m6 (1.5-2.5 hr and 4-8 ml' kg-'. min -t, for midazolam vs 5-11.5 hr and !.6-4.3 ml.kg -n .min -~, for thiopentone). Because of these pharmacokinetic differences and the time of measurements, we may have underestimated the thiopentone-midazolam differences in arrhythmogenic threshold to epinephrine. Based on the reported pharmacokinetic behaviour of thiopentone and midazolam, t6 the rapid decline in plasma levels of both drugs had already occurred when we began MAIRE measurements two hours after induction of anaesthesia, with plasma levels decreasing slowly during the time of measurements. We may also have underestimated thiopentone's arrhythmogenic potential, which may explain why our MAIRE (1.63 I~g" kg -~' min -j) was higher than that reported by some. nT,ns Others found MAIREs higher than ours, n9-22 probably because our methodology included higher doses of thiopentone (25-30 mg" kg -t vs 20 mg" kg-t), N20 (50% N20 in 02 vs 100% O2), a lower halothane concentration (1 MAC vs 1.1 to 1.25 MAC) , and a longer epinephrine infusion time (5 min vs 3 min). Ten-minute intervals separated consecutive infusions to allow haemodynamic variables to return to within 10% of control, as in the studies of Pace et al. no and Kapur et al. 20 The arrhythmogenic threshold of epinephrine has been reported as infusion rate, 17'19'2~ dose s'14 (infusion rate x duration of infusion), or both. 25 We reported infusion rates and plasma levels of epinephrine, with the latter probably being more relevant.
In dogs anaesthetized with halothane after thiopentone induction, aminophyUine 10 mg.kg -n did not cause arrhythmias, t5 but did enhance the arrhythmogenicity of epinephrine, ts'|9 To our knowledge, a dose-related arrhythmia-facilitating effect of aminophylline has not been clearly reported. Aminophylline 10 mg.kg -I decreased MAIRE and MAPC; aminophylline 20 mg" kg-' decreased MAIRE further, with a downward trend in MAPC (Table 1) . At each determination, both MAIRE and MAPC were higher after midazolam than after thiopentone (Table I ). The midazolam/thiopentone MAIRE and MAPC ratios increased with aminophylline (M/T MAIRE and MAPC ratios: 1.54 and 1.89 at Ao; 2.12 and 2.55 at Ato; 2.12 and 3.09 at A2o), suggesting that midazolam-aminophylline was a less arrhythmogenic combination than thiopentone-aminophylline.
The arrhythmogenic threshold to epinephrine can be altered by iv anaesthetic induction agents, 5't8'2' halogenated volatile anaesthetics, 26 and aminophylline. '8't9 Our study was not designed to investigate if more complex cellular mechanisms such as the interaction of cAMP with free intracellular Ca ++ ,27 reuptake of adenosine, 2s sensitization of the A-V node 29 were responsible for alterations of the arrhythmogenic threshold to epinephrine. However, we were able to assess the role of the blood pressure response to epinephrine, 6 plasma potassium concentrations, 3~ and acid-base status at in causing the observed MAIRE differences between thiopentone and midazolam induction.
Systolic blood pressure at the time of the arrhythmias was nearly identical between groups before aminophylline, although barbiturates and benzodiazepines may not have identical influences on the autonomic nervous system components. Thiopentone reportedly decreases the activity of baroreceptors 32 and the sympathetic activi-ty of cutaneous nerves, 33 inhibits cervical sympathetic preganglionic activity, 32 and allows induction of anaesthesia without sympathetic activation 34 (thiopentone bolus plus infusion decreased plasma norepinephrine after ten minutes; giving thiopentone just before induction of anaesthesia by mask with halothane prevented the sympathetic activation seen with mask induction alone). Midazolam has been reported to decrease central sympathetic outflow, to lower circulating concentrations of catecholamines, and to decrease transiently baroreceptor activity. 35 To our knowledge, no systematic investigation exists comparing the autonomic nervous system effects of benzodiazepines and barbiturates. At A lo and A20, systolic blood pressure was higher after midazolam than after thiopentone (Table 1 ). This may have been more an effect than a cause since more epinephrine was required with midazolam to reach the arrhythmogenic threshold. Thus, increased midazolam/thiopentone MAIRE and MAPC ratios after aminophylline may explain the SBP differences between groups. Hypotension may be arrhythmogenic, but the lowest SBP at arrhythmias was 124 mmHg (group T at A2o). Neither hyper-nor hypotension appear to contribute to the inter-group differences in arrhythmogenic thresholds, reinforcing the conclusion of Atlee and Malkinson 5 that the systolic blood pressure response to epinephrine does not explain the increase in arrhythmogenicity after thiopentone.
Plasma potassium concentration was initially the same in both groups, then decreased after aminophylline 10 mg.kg-t in group T, but with only a small downward trend after aminophylline 20 mg-kg-~ in group M (Table  1) . Hypokalaemia may have facilitated arrhythmias with the aminophylline-thiopentone combination.
Acid-base imbalance did not appear to contribute to the arrhythmias, since arterial pH and PCO2 did not differ between groups nor change during the study (Table II) .
In summary, if maintenance of anaesthesia with halothane is considered important when a potential aminophylline-epinephrine arrhythmogenic interaction may occur, then replacing thiopentone with midazolam as the induction agent could be advantageous.
